DCGI issues alert on suspected falsified GLP-1-RA products in the market
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 23, 2023
The Central drug regulator has issued alert on suspected falsified versions of Glucagon-like peptide 1 receptor agonist (GLP-1-RA) products, an anti-diabetes management drug, in the market. GLP-1-RA […]
Let's personalize your content